The Dermatology Digest Podcast Exclusives: Recent Episodes
The Dermatology Digest
Dr. Patricia Farris discusses a variety of skincare trends, including clean beauty, green beauty, and a new concept: freshly activated beauty.
Dr. Ted Lain discusses dose duration among neurotoxins, including efficacy, endpoints, and patient expectations.
Dr. Jeanine Downie discusses non-Invasive fat removal, including technology evolution, treatment approach, results, and combination therapies.
Dr. Joel L. Cohen discusses the lidocaine shortage, including the use of varied anesthetic formulations and need for recognizing the symptoms of lidocaine toxicity.
Dr. Ronald Moy provides an update in botulinum toxins, including dosing and dilution and how to differentiate your practice by minimizing pain and bruising.
Dr. Joel L. Cohen discusses dermal filler-related complications, including strategies for prevention and management.
Actinic keratoses are the second most common reason patients visit the dermatologist. In the final podcast in this 3-part educational program, Dr. Neal Bhatia discusses tips and provides advice for AK management, including treatment, reimbursement, and more. Here’s Dr. Bhatia
Drs. George Martin and Ted Rosen continue their discussion on field therapies, including less versatile and combination treatment options.
Photodynamic therapy has become a safe, effective, and painless option for treating actinic keratosis. In the final podcast in this 3-part series, The Real World of PDT, Drs. George Martin and Ted Rosen discuss the range of FDA-approved field therapies, including on- and off-label protocols to enhance efficacy, decrease side effects, and increase patient compliance.
Dr. Carl Thornfeldt discusses the science behind herbal-based therapies as well as the complexities of herbal therapy product development.
Actinic keratoses are the second most common reason patients visit the dermatologist. In the second podcast of this educational program, Dr. Todd Schlesinger, Medical Director, Dermatology and Laser Center of Charleston and Fellow, American Society for Mohs Surgery, discusses new and emerging topical treatments for AKs, including photodynamic therapies, topical agents, and more.
Drs. George Martin and Daniel Siegel discuss PDT coding and reimbursement in more detail with practical in-office tips and scenarios.
In part 2 of this 3-part podcast series, The Real World of PDT, Drs. George Martin and Daniel Siegel discuss PDT coding and reimbursement, including an overview of the evolving landscape and nuances for treatment, billing, and patient satisfaction.
Actinic keratoses are the second most common reason patients visit the dermatologist. In the first podcast of this educational program, Dr. Deborah Sarnoff, Clinical Professor of Dermatology, NYU, and President of the Skin Cancer Foundation, discusses the clinical characteristics of AK, including symptoms, histology, and risk for SCC development.
Welcome back as Dr. George Martin and Edward Maytin continue their discussion on PDT, including details on implementing the painless PDT protocol, treating resistant scalp AKs, and using PDT for other superficial skin cancers.
Photodynamic therapy has become a safe, effective, and painless option for treating actinic keratosis. In part 1 of this 3-part podcast series, The Real World of PDT, Drs. George Martin and Edward Maytin discuss the evolution of photodynamic therapy protocols, including daylight mediated PDT, in-office painless parameters, and pretreatment with vitamin D.
Oral antibiotics are frequently used to treat moderate to severe acne. In the final podcast in this 3-part series, Emmy Graber, MD, MBA, President, The Dermatology Institute of Boston, and Affiliate Clinical Instructor, Northeastern University, Boston, Massachusetts, shares pearls for using sarecycline as an oral antibiotic therapy for acne.
Photodynamic therapy has become a safe, effective, and painless option for treating actinic keratosis. In the introduction to this 3-part series on PDT, Dr. George Martin, dermatologist and founder and program chairman of Maui Derm, Maui, Hawaii, introduces three of the world's leading authorities on PDT who help to dispel the misconceptions that PDT is a painful, expensive, and ineffective treatment.
Oral antibiotics are frequently used to treat moderate to severe acne. In the first podcast in this 3-part series, Christopher Bunick, MD, PhD, Associate Professor of Dermatology, Yale School of Medicine, New Haven, Connecticut, discusses indications, concerns, and improvements in oral antibiotic therapy for acne.
Oral antibiotics are frequently used to treat moderate to severe acne. In the first podcast in this 3-part series, Dr. Christopher Bunick discusses indications, concerns, and improvements in oral antibiotic therapy for acne.
Dr. Jason Emer shares his experience with plasma pen technology for safe and effective skin tightening, including device selection, application, and skincare regimens.
With age, skin becomes thinner, wrinkles, fragile and can bruise and tear more easily. In the final podcast in this 3-part series that addresses aging skin and improving skin health, board-certified dermatologists, Dr. Joel Schlessinger and Dr. Roger Ceilley discuss medical interventions for mature skin, including specific ingredients and topical formulations designed to reduce the incidence and duration of bruising. Here’s Drs. Schlessinger and Ceilley.
Skin aging is more than cosmetic. In addition to overall thinning, wrinkles, and pigmentary changes, skin becomes fragile and can bruise and tear more easily. In the second podcast in this 3-part series that addresses aging skin and improving skin health, board-certified dermatologists, Dr. Roger Ceilley and Dr. Joel Schlessinger discuss the pathology of actinic purpura, including social impact and strategies for reducing risk. Here’s Drs. Ceilley and Schlessinger.
Skin aging is more than cosmetic. In addition to overall thinning, wrinkles, and pigmentary changes, skin becomes fragile and can bruise and tear more easily. In this, the first of three podcasts that address aging skin and improving skin health, board-certified dermatologists, Dr. Joel Schlessinger and Dr. Roger Ceilley discuss the characteristics and causes of aging skin, including an overview of options for intervention.
Dr. Nathaniel J. Jellinek discusses raising awareness about nail issues as well as specific Mohs techniques to improve nail unit squamous cell carcinoma (SCC) treatment outcomes.
Dr. Jacqueline Watchmaker shares her experience with non-surgical facial skin tightening devices, including candidate selection, realistic expectations, and optimal outcomes.
Drs. George Martin and Ted Rosen talk candidly about why JAK inhibitors are important in the treatment of atopic dermatitis (AD), when dermatologists should consider using them, and how to safely mitigate risks and side effects while effectively treating AD patients with these powerful, “revolutionary” medications.
0:50 – The role of JAKs in AD
4:50 – JAK nuances
9:13 – The ORAL study and expanded black box warning
15:07 – Newer JAKS and Black Box inheritance
17:00 – The new molecules
18:00 – How to present biologics vs JAKs (age + delivery)
21:10 – Women of childbearing years
27:00 – Legacy black box on mace events, PEs, and DVTs – who’s at risk?
30:44 – Cancer and risk
32:10 – Patients at risk for serious infections
35:27 – JAKs and vaccinations
38:47 – Dosing adjustments
46:20 – Final thoughts on biologics and JAKs
Dr. Stephen Tyring discusses the safety and efficacy of the shingles vaccine, including the dermatologist’s role in the public health effort to prevent reemergence of the virus.
Dr. Sergei Grando discusses his multidrug protocol shown to offer potential cure for the majority of pemphigus and pemphigoid patients.
Dr. Heather Woolery-Lloyd discusses approaches for treating facial acanthosis nigricans in children and adults.
Dr. Heather Woolery-Lloyd shares tips for differentiating among the various types scarring alopecia.
Dr. JiaDe Yu discusses pre-emptive avoidance strategies for common sources of pediatric allergic contact dermatitis.
Dr. Raja Sivamani discusses the need for a broader concept of sun protection as well as a more holistic approach to melasma.
Polypodium leucotomos extract (PLE) is derived from a South American fern known to provide protection against solar UV radiation exposure. In the third and final podcast in this series, board-certified dermatologists Dr. Joel Schlessinger and Dr. Jeanine Downie discuss the benefits of PLE supplementation for inflammatory skin conditions, including polymorphous light eruption, rheumatoid arthritis, vitiligo, psoriasis, and more.
Dr. Raj Chovatiya discusses the safety and efficacy of dupilumab for atopic dermatitis, asthma, and chronic rhinosinusitis as well as its broad potential for treating other conditions affected by the IL-4/IL-13 signaling pathway. Based on the presentation "Dupilumab: Going Beyond Atopic Dermatitis" at the Diversity in Dermatology 2022 Conference.
Polypodium Leucotomos extract (PLE) is derived from a South American fern known to provide protection against solar UV radiation exposure. In the second podcast in this series, board-certified dermatologists Dr. Joel Schlessinger and Dr. Jeanine Downie discuss in detail the benefits of PLE supplementation for preventing skin damage from sun exposure.
Dr. Joel Cohen details several recent cosmetic dermatology devices, including one has reignited interest in laser hair removal, another for nonsurgical eyelid ptosis, and more.
Polypodium leucotomos extract is derived from a South American fern known to provide protection against solar UV radiation exposure. In this, the first of three podcasts, board-certified dermatologists Dr. Joel Schlessinger and Dr. Jeanine Downie discuss the history of polypodium leucotomos, including current formulations and applications.
Dr. James Spencer discusses the regulatory background of sunscreen ingredients, including testing requirements for systemic effects, and how that influences his recommendations to patients.
Dr. Vishal Anil Patel discusses the opportunities, challenges, and potential for artificial intelligence in dermatology.
Dr. Joel Cohen discusses laser and light innovations that provide solutions for delivering safe and efficacious patient results.
Dr. Brittany Craiglow discusses the latest options for treating pediatric patients with hair loss disorders.
Dr. George Martin discusses Maui County Bill 135, a ban on chemical sunscreens, which recently passed despite oppositional expert testimony, as well as measures that may affect or prevent the bill from becoming law in October 2022.
Dr. Joslyn Sciacca Kirby discusses the dermatologist’s role in recognizing skin changes associated with polycystic ovary syndrome.
Dr. David Goldberg discusses avoiding and addressing aesthetic treatment complications to minimize legal risk.
Dr. Raja Sivamani talks probiotics, including evidence, products, and indications for dermatologic conditions.
Dr. Suneel Chilukuri discusses a specific technique and technology for nonsurgical facial sculpting and tightening.
Dr. Melissa Mauskar discusses the dermatologist’s role in diagnosing and managing vulvovaginal disorders, including when to involve the patient’s gynecologist.
Dr Robert Brodell offers biopsy tips for getting an accurate pathology report that correctly diagnoses skin diseases porokeratosis and bullous pemphigoid.
Dr. Robert Brodell draws on 27 years of experience in private practice to impart wisdom (and humor) on a simple but useful in-office procedure: cyst removal.
Dr. Rick Fried offers advice and discusses strategies for effectively managing the difficult parents of acne patients.
Dr. Rick Fried offers advice and discusses strategies for effectively connecting with and treating the emotional or noncommunicative acne patient.
In his latest rant, Dr. Ted Rosen says giving advising students to “follow your passion” is not only cliche, it could be a setup for failure.
In his latest rant, Dr. Ted Rosen admits he's bad at delegating... but he's working on it (and finding the rewards can be sweet).
Dr. Nicholas Brownstone discusses the evaluation process and building rapport with dermatology patients who present with delusions of parasitosis.
Daniel Butler, MD, discusses the use of Dupilumab for treating Grover disease and possible pathophysiology insights based on a recent case series in JAMA Dermatology.
In the final episode of our podcast series on BPDCN, dermatologist and dermatopathologist Dr. Whitney High discusses disease prognosis and offers guidance for referring patients to a hematologist oncologist.
This is part 3 in The Dermatology Digest’s 3-part educational podcast series, sponsored by Stemline, which provides an overview of BPDCN, including the dermatologist’s important role in diagnosis and referral.
Sheila Friedlander, Scripps Clinic, San Diego, to discuss recent developments in tinea capitis, including epidemiology, diagnosis, and treatment.
Dr. George Cohen discusses misconceptions about skin cancer in skin of color as well as increased risk factors and lesion recognition.
Dr. James Treat discusses current and future monoclonal antibodies for atopic dermatitis treatment, including dupilumab, tralokinumab, and lebrikizumab.
Dr. Brent Moody discusses non-medical switching and formulary exclusions, how they affect both dermatology patients and practices, and what the dermatologist can do to advocate for their patients.
Dr. Madelaine Feldman discusses non-medical switching in the dermatology and rheumatology specialties, including the role of pharmacy benefit managers, and the Safe Step Act.
Steven Newmark, Director of Policy, Chief Legal Officer of the Global Healthy Living Foundation (GHLF), discusses the Foundation’s position on non-medical switching, the repeal process, and the dermatologist’s supporting role.
The zombie apocalypse meets the dermatology practice in Dr. Ted Rosen's talk this month about lessons gleaned from his favorite genre, including strength in unity, identifying the real enemy, and despite it all, finding ways to have fun.
In part 2 of this 3-part series, Dr. Whitney High details the BPDCN diagnosis process, including the triad of proteins that may indicate a positive diagnosis, as well as common misdiagnoses.
From the 2021 Maui Derm Connect Meeting, Dr. Ilona Frieden offers several tips and tricks to minimize pain local injection pain for the pediatric patient.
PODCAST
Ted Rants #3 Listen Up! Hear Here!
Ted Talks but sometimes Ted Rants. This time? He sounds off on the (nearly) lost skill of taking a good patient history at the outset of the diagnostic process.
From the 2021 Maui Derm Connect Meeting, Dr. Pearl Grimes reviews the pathogenesis of dyspigmentation, including hyperpigmentation and vitiligo.
Dr. John Barbieri discusses recent research that examines the dermatologist’s possible role as primary care physician for some patients.
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, yet aggressive and challenging-to-diagnose blood cancer that nearly always presents with cutaneous involvement. In this first episode of The Dermatology Digest’s 3-part educational podcast series, dermatologist and dermatopathologist Dr. Whitney High discusses BPDCN patient demographics and the characteristics of cutaneous lesions.
In our cannabinoid series that examines current dermatologic pros and cons, Dr. Shawn Kwatra is cautiously optimistic, but advises to proceed with caution.
In our cannabinoid series that examines current dermatologic pros and cons, Dr. Adam Friedman talks CBD vs medical cannabis, dispensaries, and navigating state regulations.
In our cannabinoid series that examines current dermatologic pros and cons, Dr. Adam Friedman discusses the potential for CBD in dermatology, the science, and current clinical trial programs.
The recent winter storm in Texas has Ted Rosen, MD, talking adversity, resilience and hope in medicine and in life.
Dr. Mayar Mohajer discusses data he presented at IDWeek 2020 that examines what happens to COVID rates of infection when healthcare workers wear face shields and masks together.
Ted Talks, but sometimes Ted Rants. This time? He's perturbed about the sometimes-sinister side of posters.
Todd Schlesinger, MD, discusses advanced treatment for advanced skin cancers from the 2020 Fall Clinical Dermatology Conference.
Heather Woolery-Lloyd, MD, a board-certified dermatologist and a member of the American College of Lifestyle Medicine, discusses the six lifestyle interventions to treat age-related and chronic dermatologic diseases—and provides their evidence bases.
Dr. Keri highlights recent research that links the role of diet to many common dermatological conditions—especially those with an inflammatory component.
Ted Talks, but sometimes Ted Rants. This time? He's vexed about COVID vaccine non-planning.
In this exclusive TDD podcast, Mark D. Kaufmann, MD, unpacks the first major overhaul to the AMA’s CPT codes in 25 years, impacting not just how dermatologists code—but how billing changes as a result.
Instinctively, dermatologists might think it best to slow or stop practice marketing during pandemic shutdowns and through the uncertainty.
But marketing pro Risa Goldman Luksa tells The Dermatology Digest she recommends that dermatology practices rev up some aspects of their marketing campaigns while limiting others to maximize profit potential and minimize expenses.
Welcome to the inaugural issue of The Dermatology Digest! I am honored to have been asked to serve as this publication’s Editor-in-Chief.
Although I am certainly not a mind reader, I know what you’re thinking right now: Why, oh why, should there be yet another magazine dedicated to the field of dermatology?
TDD sits down with Pediatric Dermatologist Bernard Cohen, MD, from Johns Hopkins to discuss the latest acne agents and patient pointers for their use.